Skip to main content
LLM 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Session VIII: Indolent Lymphomas and CAR-T Cells

Debate: Patients with Recurrent Follicular Lymphoma Should Receive CAR-T Cells vs Bispecific Antibodies - BISPECIFIC ANTIBODIES

Thursday, October 19, 2023
4:40 PM - 4:55 PM ET
Location: Metropolitan East